In glioma, KAT6B facilitates the acetylation of histone H3 at lysine 23 and the enrichment of RNA polymerase II at the STAT3 promoter in glioma cells, thereby promoting STAT3 expression and exerting an inhibitory effect on ferroptosis [230]. This evidence concerns the gene STAT3 and central nervous system cancer.